Insights Category: Blog

XDrug.AI — AI Where the Lab Already Is

Most AI platforms stop at a ranked list. XDrug.AI runs seven integrated modules inside ChemPartner's CRO, so predictions get synthesized, tested and used to retrain the model on your own series.

16 9 月, 2026

Blog: Matching Preclinical Models to Late-Stage Disease

The Metastatic Challenge: Matching Preclinical Models t […]

30 6 月, 2026

Blog: Beyond Subcutaneous Models

Beyond Subcutaneous Models: Rethinking Implantation Sit […]

6 6 月, 2026

Blog: Syngeneic Tumor Models

Syngeneic Tumor Models: The Gold Standard for Preclinic […]

28 5 月, 2026

More Than the Sum of Parts: Dual-Payload ADCs and the Art of DAR Optimization

Antibody Drug Conjugates (ADCs) combine targeting preci […]

28 1 月, 2026

Unlocking New Targets: Cytokine Receptor Platform for Immunology Innovation

Cytokines and their receptors orchestrate intricate imm […]

15 1 月, 2026

From Neurons to Networks: High-Throughput Epilepsy Models for Translational Neuroscience

The Importance of Preclinical Models in Epilepsy Drug D […]

4 1 月, 2026

Engineering Smarter ADCs: Novel Linkers for Better Safety and Efficacy

Antibody-drug conjugates (ADCs) are complex therapeutic […]

3 11 月, 2025

One Antibody, Many Tasks: The Rise of Multi-Specific ADCs

Multispecific ADCs: Solutions to Oncology’s Toughest Hu […]

24 10 月, 2025

Spotlight on Psoriasis – Advanced IL-23 Inhibitor Preclinical Screening Assays for Better Outcomes for Patients

Psoriasis: Patient Impact and the Path to Innovation Ps […]

16 10 月, 2025